Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Bioinformatics (Oxford, England)|September 26, 2013
Methods and challenges in timing chromosomal abnormalities within cancer samplesElizabeth Purdom, Christine Ho, Catherine S Grasso, et al.
Cancer Letters|December 12, 2022
PAK4 inhibition improves PD1 blockade immunotherapy in prostate cancer by increasing immune infiltrationShengchen Su, Sungyong You, Yanping Wang, et al.
Neoplasia (New York, N.Y.)|December 2, 2011
Detection of somatic copy number alterations in cancer using targeted exome capture sequencingRobert J Lonigro, Catherine S Grasso, Dan R Robinson, et al.
Molecular and Cellular Endocrinology|September 23, 2017
Integrated molecular analysis of Tamoxifen-resistant invasive lobular breast cancer cells identifies MAPK and GRM/mGluR signaling as therapeutic vulnerabilitiesHillary Stires, Mary M Heckler, Xiaoyong Fu, et al.
Plos One|April 6, 2018
IL-13 receptors as possible therapeutic targets in diffuse intrinsic pontine gliomaNoah E Berlow, Matthew N Svalina, Michael J Quist, et al.
Sarcoma|June 23, 2020
Deep Functional and Molecular Characterization of a High-Risk Undifferentiated Pleomorphic SarcomaNoah E Berlow, Catherine S Grasso, Michael J Quist, et al.
Virchows Archiv : an International Journal of Pathology|December 16, 2014
Tumor evolution and progression in multifocal and paired non-invasive/invasive urothelial carcinomaJoshua I Warrick, Daniel H Hovelson, Anmol Amin, et al.
BMC Cancer|May 9, 2020
Chromosomal instability in untreated primary prostate cancer as an indicator of metastatic potentialEric T Miller, Sungyong You, Radu M Cadaneanu, et al.
Human Pathology|August 7, 2014
HRAS mutations are frequent in inverted urothelial neoplasmsAndrew S McDaniel, Yali Zhai, Kathleen R Cho, et al.
Molecular Cancer Research : MCR|January 17, 2015
Next-Gen Sequencing Exposes Frequent MED12 Mutations and Actionable Therapeutic Targets in Phyllodes TumorsAndi K Cani, Daniel H Hovelson, Andrew S McDaniel, et al.
Pageof 2